
Latest News

Iktos announces strategic collaboration with Cube biotech
We are thrilled to announce our strategic partnership with Cube Biotech! The synergy between Cube Biotech's advanced membrane protein technology and Iktos' AI-driven drug discovery platform will help us develop novel small molecule agonists of the Amylin Receptor — a target with transformative potential for addressing obesity, diabetes, and other cardiometabolic disorders.
Press release
Press articles and news

Iktos: the marriage of AI and robotics in the service of drug discovery
Our CEO, Yann Gaston-Mathé, shared Iktos’ story and vision in a recent interview with Techniques de l'Ingénieur.
Press Kit

Contact
For any communication need please contact our agency.
Ulysse Communication
Mail : iktosteam@ulysse-communication.com
Tel. : +33663665922